ODAC votes Yes on advanced multiple myeloma agent with ocular toxicity July 17, 2020Vol.46 No.29By Paul Goldberg
Future of telehealth uncertain as CMS, private insurers reexamine payment policies put in place in March July 17, 2020Vol.46 No.29By Matthew Bin Han Ong
Drugs & Targets Keytruda’s sBLA receives Priority Review from FDA for second-line treatment of relapsed or refractory classical Hodgkin lymphoma July 10, 2020Vol.46 No.28
Drugs & Targets Lynparza approved in EU for germline BRCA-mutated metastatic pancreatic cancer July 10, 2020Vol.46 No.28
Clinical Roundup Drug screens and CRISPR combine to make better cancer drugs, collaboration of researchers say July 10, 2020Vol.46 No.28
Clinical Roundup Fasting Mimicking Diets may enhance effectiveness of chemotherapy in cancer patients July 10, 2020Vol.46 No.28
Funding Opportunities DoD Pancreatic Cancer Research Program funding opportunities for FY20 July 10, 2020Vol.46 No.28
Funding Opportunities Defense Health Program DoD Rare Cancers Research Program anticipated funding opportunities for FY20 July 10, 2020Vol.46 No.28
